Contraline, a company based in Charlottesville, Virginia, is working on introducing a new method for male contraception that may overcome many of the limitations of existing approaches, particularly vasectomy. Contraline’s procedure is called Vasintomy and like vasectomy it works by preventing sperm from moving down the vas deferens. Unlike vasectomy, though, it’s a non-surgical procedure that doesn’t permanently reconstruct male anatomy and should be reversible. We spoke with Kevin Eisenfrats, co-founder and CEO of Contraline, to get a better idea of the technology and what we can expect from the company in the future.
